The Team Driving Breakthroughs from Setbacks

Paul Wolfe is an accomplished leader with extensive experience in technology firms, serving as President, COO, and Board Director. As the founding President of North America for Cambridge Quantum Computing, he helped establish Quantinuum, the largest privately held quantum computing company. Previously, he was COO at Mission Measurement, a global strategy advisory firm, and a Principal at RCM, which had over $4B in AUM.  His career includes roles at GE Capital and Bain & Company.          He holds a B.A. from Williams       College and an MBA from the           University of Chicago Booth School of Business.

Takis, a mathematician has studied extensively at the University of Cambridge,  is also a skilled computer programmer, contributing to major open-source projects like X11, GCC, and Mozilla Firefox. In 2014, he co-founded Cambridge Quantum Computing (now Quantinuum), one of the world’s leading quantum software companies. Takis led the development of TKET, a cutting-edge quantum computing framework, and is now focused on quantum applications in finance, climate modeling, and biology. His team grew rapidly, securing $50M    in funding and advancing          quantum secure technologies.

Ahmed has a PhD in genetics and dual master’s degrees from NYU in clinical informatics. He has over     25 years of experience in bioinformatics, clinical informatics, and molecular biology. He has held academic positions at Yale, NYU, and Vanderbilt, and co-led numerous international research initiatives. He has had extensive success consulting in the commercial biotechnology sector. Dr. Fadiel has nearly 100 publications and has chaired workshops globally. He now co-directs the Computational Oncology Unit at the University of Chicago.

Adam Koster is a distinguished serial entrepreneur and regenerative medicine executive, specializing in business development and company formation. He excels at building high-performance teams and relationships, driving productivity within biotechnology firms. With extensive experience in generating partnerships with pharmaceutical companies and mid-size life sciences organizations, Adam demonstrates exceptional problem-solving skills. His strong management abilities enable him to motivate teams and navigate complex organizations effectively.